Maya EDU vs IVUSAID

MayaEDU is a unique interactive flip clinical-education tool for diagnosis and critical-thinking training. Medical students, residents, and instructors can be used in real time in class, during rounds, or on their own. Established medical cases can be uploaded to the platform and instructors can disseminate medical cases and observe how students evaluate cases through the web-based platform. Why MayaEDU? 1. MayaEDU provides a full differential diagnosis engine that can process any number and/or combination of symptoms, signs, labs, tests, medications, past medical history. 2. Guides the students on relevant patient interview questions. 3. Helps the student understand the relevant labs, radiology test, and physical signs to take to refine the diagnosis. 4. Students can reorder their differential list as well as generate their own differential diagnosis list. 5. Real-time cases promote an unmatched learning experience. 6. Instructor can take students through required case studies and evaluate student’s understanding & decision-making process. 7. Instructor and students can post forum discussions on MayaEDU’s social platform, Xynapse™. 8. Instructor can watch their students’ screens in real time as they respond to questions creating the ability to evaluate the student’s clinical reasoning skill. 9. Technology to increase student participation rates 10. Instructor and admin can create groups that correspond to classes and specific grouping of students. 11. Schools can brand the app and upload medical cases to the platform. 12. Complementary professional clinician app (MayaPro) and patient app (MayaMD) In 2015, the National Academy of Medicine (NAM) published “Improving Diagnosis in Health Care” revealing diagnostic error will occur at least once in the lifetime of every American, affect 5% of all adults seeking out patient care each year, be associated with 10% of all patient deaths, cause 6 to 17% of all adverse events in hospitals, andi be the leading reason of paid medical malpractice claims. Some authorities would go further to suggest that diagnostic error represented the third leading cause of death in America (behind cardiovascular disease and cancer) with estimates ranging from 250,000 to 400,000 premature deaths occurring annually. Reinforcing this message, the ECRI Institute identified diagnostic error as their top patient safety priority in 2018. Without appropriate diagnosis, patients are at substantial risk of harm. The optimization of two core diagnostic performance metrics (accuracy and efficiency) will redefine the meaning of ‘quality health care’ in the 21st century.

The IVUSAID App is a free educational mobile application which has been developed to teach medical professionals how to use intravascular ultrasound (IVUS) for PCI guidance based on the current guidelines using our extensive experience and large database of complex coronary cases. Despite the growing body of evidence for clinical benefits of IVUS-guided PCI, IVUS remains underutilized in much of the world including the United States. Challenges in image interpretation and education are among the barriers to widespread adoption of IVUS in everyday clinical practice. Mount Sinai Heart is a global leader within the field of interventional cardiology as well as mobile apps development. The myriad of cases and pathology which are seen in The Mount Sinai Cardiac Catheterization Laboratory make it the perfect center to educate medical professionals within this field. The Key Concepts section of IVUSAID describes principles of IVUS, image acquisition, and concepts of ultrasound behavior in various tissues. The Image Interpretation section of the app has dozens of representative cross-sectional images, videos, and descriptions of plaque types, stent apposition and expansion, artifacts, and more. A short video for each type of lesion or artifact and post-stent findings, in addition to an annotated representative cross section aims to overcome a major limitation of any article or book on IVUS which present a static image, since the actual IVUS pullback is dynamic. Twenty-one complex coronary cases demonstrate IVUS guidance in a variety of patient presentations and lesions including ACS, LM bifurcation, severely calcified lesions and calcified nodules, spontaneous coronary artery dissection, and malapposed stents as well as how IVUS was used to inform treatment decisions. An extensive quiz section helps deliver educational content in a more interactive format where answers are accompanied by detailed explanations and references. We hope that IVUSAID will help techs, fellows, and early-career physicians incorporate IVUS in their daily practice for stent sizing, post-stent optimization, and identification of appropriate treatment strategies.